Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
MDGL

MADRIGAL PHARMACEUTICALS (MDGL) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $471.75 -1.1% on the day +10.1% over 12 months 52-week range $412.35 – $602.83

Share price and insider trades

MDGL closeInsider buyInsider sale
400500600700NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $341,940 on 2026-08-17 · Shannon T KelleySold $435,420 on 2026-05-18 · David SoergelSold $505,389 on 2026-03-02 · Mardi DierSold $516,561 on 2026-06-01 · David SoergelSold $1,082,986 on 2025-11-21 · Carole HuntsmanSold $1,368,253 on 2026-07-20 · William John SiboldSold $1,380,816 on 2025-12-04 · William John SiboldSold $1,442,516 on 2026-01-20 · Rebecca Taub, Shannon T KelleySold $1,544,481 on 2026-01-26 · Carole Huntsman, Rebecca Taub, William John SiboldSold $2,120,873 on 2026-03-06 · Carole Huntsman, Mardi Dier, Rebecca Taub, Shannon T Kelley, William John SiboldSold $2,413,416 on 2025-12-02 · Mardi DierSold $2,831,792 on 2026-09-11 · William John SiboldSold $2,928,718 on 2026-05-22 · Richard S LevySold $3,407,392 on 2026-09-09 · William John SiboldSold $4,428,193 on 2025-11-13 · Richard S LevySold $8,027,360 on 2025-11-05 · Kenneth BateSold $22,712,704 on 2026-01-09 · Paul A Friedman, Rebecca TaubSold $23,991,744 on 2025-12-10 · Paul A Friedman, Rebecca Taub
Bought, 12 months$0
Sold, 12 months$81.5M
Insiders buying0
Insiders selling9

MADRIGAL PHARMACEUTICALS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 9 sold $81.5M of MDGL stock on the open market.

MDGL insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $41.3M sold (70 trades)Q4 2025Q1 2026: $28.3M sold (83 trades)Q1 2026Q2 2026: $3.9M sold (14 trades)Q2 2026Q3 2026: $7.9M sold (35 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$7.9M35
Q2 2026—0$3.9M14
Q1 2026—0$28.3M83
Q4 2025—0$41.3M70

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.0×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 MADRIGAL PHARMACEUTICALS, INC. insiders reported open-market purchases totaling $0, while 9 insiders reported sales totaling $81.5M. 170 of 202 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 11SEC William John SiboldCEO, President Sell Plan 1,539198,627 held (−1%) $544.02 $837K -13.3% —
Sep 11SEC William John SiboldCEO, President Sell Plan 1,202200,166 held (−1%) $542.60 $652K -13.1% —
Sep 11SEC William John SiboldCEO, President Sell Plan 1,040205,369 held (−1%) $536.11 $558K -12.0% —
Sep 11SEC William John SiboldCEO, President Sell Plan 761197,866 held (−0%) $544.83 $415K -13.4% —
Sep 11SEC William John SiboldCEO, President Sell Plan 687201,736 held (−0%) $540.59 $371K -12.7% —
Sep 11SEC William John SiboldCEO, President Sell Plan 644206,409 held (−0%) $535.27 $345K -11.9% —
Sep 11SEC William John SiboldCEO, President Sell Plan 640204,729 held (−0%) $537.17 $344K -12.2% —
Sep 11SEC William John SiboldCEO, President Sell Plan 520204,209 held (−0%) $538.30 $280K -12.4% —
Sep 11SEC William John SiboldCEO, President Sell Plan 522208,329 held (−0%) $530.23 $277K -11.0% —
Sep 11SEC William John SiboldCEO, President Sell Plan 512207,449 held (−0%) $533.09 $273K -11.5% —
Sep 11SEC William John SiboldCEO, President Sell Plan 505203,489 held (−0%) $540.19 $273K -12.7% —
Sep 11SEC William John SiboldCEO, President Sell Plan 396207,053 held (−0%) $534.20 $212K -11.7% —
Sep 11SEC William John SiboldCEO, President Sell Plan 368201,368 held (−0%) $541.64 $199K -12.9% —
Sep 11SEC William John SiboldCEO, President Sell Plan 362203,127 held (−0%) $541.65 $196K -12.9% —
Sep 11SEC William John SiboldCEO, President Sell Plan 368207,961 held (−0%) $531.99 $196K -11.3% —
Sep 11SEC William John SiboldCEO, President Sell Plan 347208,851 held (−0%) $529.27 $184K -10.9% —
Sep 11SEC William John SiboldCEO, President Sell Plan 218202,583 held (−0%) $535.94 $117K -12.0% —
Sep 11SEC William John SiboldCEO, President Sell Plan 215203,994 held (−0%) $539.03 $116K -12.5% —
Sep 11SEC William John SiboldCEO, President Sell Plan 160202,967 held (−0%) $542.55 $87K -13.0% —
Sep 11SEC William John SiboldCEO, President Sell Plan 160202,423 held (−0%) $537.62 $86K -12.3% —
Sep 11SEC William John SiboldCEO, President Sell Plan 131209,198 held (−0%) $527.88 $69K -10.6% —
Sep 11SEC William John SiboldCEO, President Sell Plan 120197,746 held (−0%) $546.38 $66K -13.7% —
Sep 11SEC William John SiboldCEO, President Sell Plan 106202,801 held (−0%) $534.06 $57K -11.7% —
Sep 11SEC William John SiboldCEO, President Sell Plan 60202,907 held (−0%) $533.09 $32K -11.5% —
Aug 20SEC Shannon T KelleyGeneral Counsel Sell 66411,474 held (−5%) $514.97 $342K -8.4% —
Jul 20SEC William John SiboldCEO, President Sell 680209,810 held (−0%) $547.70 $372K -13.9% —
Jul 20SEC William John SiboldCEO, President Sell 545211,034 held (−0%) $544.71 $297K -13.4% —
Jul 20SEC William John SiboldCEO, President Sell 280209,329 held (−0%) $555.05 $155K -15.0% —
Jul 20SEC William John SiboldCEO, President Sell 275210,759 held (−0%) $545.71 $150K -13.6% —
Jul 20SEC William John SiboldCEO, President Sell 269210,490 held (−0%) $547.08 $147K -13.8% —
Jul 20SEC William John SiboldCEO, President Sell 153209,610 held (−0%) $550.01 $84K -14.2% —
Jul 20SEC William John SiboldCEO, President Sell 140211,689 held (−0%) $542.75 $76K -13.1% —
Jul 20SEC William John SiboldCEO, President Sell 110211,579 held (−0%) $543.79 $60K -13.2% —
Jul 20SEC William John SiboldCEO, President Sell 47209,763 held (−0%) $548.87 $26K -14.1% —
Jul 20SEC William John SiboldCEO, President Sell 1209,609 held (−0%) $550.72 $551 -14.3% —
Jun 1SEC David SoergelChief Medical Officer Sell Plan 1,04210,033 held (−9%) $495.74 $517K -4.8% —
May 22SEC Richard S LevyDirector Sell Plan 1,49722,877 held (−6%) $517.59 $775K -8.9% —
May 22SEC Richard S LevyDirector Sell Plan 78222,095 held (−3%) $518.76 $406K -9.1% —
May 22SEC Richard S LevyDirector Sell Plan 72324,374 held (−3%) $516.87 $374K -8.7% —
May 22SEC Richard S LevyDirector Sell Plan 65725,097 held (−3%) $515.92 $339K -8.6% —
May 22SEC Richard S LevyDirector Sell Plan 61026,576 held (−2%) $511.40 $312K -7.8% —
May 22SEC Richard S LevyDirector Sell Plan 43926,137 held (−2%) $512.50 $225K -8.0% —
May 22SEC Richard S LevyDirector Sell Plan 34325,754 held (−1%) $514.67 $177K -8.3% —
May 22SEC Richard S LevyDirector Sell Plan 32027,337 held (−1%) $508.24 $163K -7.2% —
May 22SEC Richard S LevyDirector Sell Plan 15127,186 held (−1%) $510.36 $77K -7.6% —
May 22SEC Richard S LevyDirector Sell Plan 8022,015 held (−0%) $519.98 $42K -9.3% —
May 22SEC Richard S LevyDirector Sell Plan 4026,097 held (−0%) $512.97 $21K -8.0% —
May 22SEC Richard S LevyDirector Sell Plan 4027,657 held (−0%) $506.68 $20K -6.9% —
May 18SEC David SoergelChief Medical Officer Sell 84411,075 held (−7%) $515.90 $435K -8.6% —
Mar 6SEC William John SiboldCEO, President Sell 1,663161,829 held (−1%) $431.94 $718K +9.2% —
Mar 6SEC Mardi DierCFO Sell Plan 64613,826 held (−4%) $431.94 $279K +9.2% —
Mar 6SEC Rebecca TaubDirector Sell 491452,213 held (−0%) $431.94 $212K +9.2% —
Mar 6SEC Carole HuntsmanChief Commercial Officer Sell 41912,692 held (−3%) $431.94 $181K +9.2% —
Mar 6SEC Mardi DierCFO Sell Plan 42013,366 held (−3%) $426.86 $179K +10.5% —
Mar 6SEC Shannon T KelleyGeneral Counsel Sell 36012,138 held (−3%) $431.94 $155K +9.2% —
Mar 6SEC Mardi DierCFO Sell Plan 16012,690 held (−1%) $434.20 $69K +8.6% —
Mar 6SEC Mardi DierCFO Sell Plan 16013,126 held (−1%) $429.00 $69K +10.0% —
Mar 6SEC Mardi DierCFO Sell Plan 12012,966 held (−1%) $430.90 $52K +9.5% —
Mar 6SEC Mardi DierCFO Sell Plan 11612,850 held (−1%) $432.56 $50K +9.1% —
Mar 6SEC Mardi DierCFO Sell Plan 8012,530 held (−1%) $436.69 $35K +8.0% —
Mar 6SEC Mardi DierCFO Sell Plan 8012,610 held (−1%) $435.32 $35K +8.4% —
Mar 6SEC Mardi DierCFO Sell Plan 8013,286 held (−1%) $427.85 $34K +10.3% —
Mar 6SEC Mardi DierCFO Sell Plan 4012,490 held (−0%) $437.65 $18K +7.8% —
Mar 6SEC Mardi DierCFO Sell Plan 4013,086 held (−0%) $429.58 $17K +9.8% —
Mar 6SEC Mardi DierCFO Sell Plan 4013,786 held (−0%) $425.08 $17K +11.0% —
Mar 2SEC Mardi DierCFO Sell 1,1839,257 held (−11%) $427.21 $505K +10.4% —
Jan 26SEC William John SiboldCEO, President Sell 1,577148,497 held (−1%) $492.42 $777K -4.2% —
Jan 26SEC Rebecca TaubDirector Sell 647452,704 held (−0%) $492.42 $319K -4.2% —
Jan 26SEC Carole HuntsmanChief Commercial Officer Sell Plan 5709,122 held (−6%) $494.59 $282K -4.6% —
Jan 26SEC Carole HuntsmanChief Commercial Officer Sell Plan 3409,692 held (−3%) $492.42 $167K -4.2% —
Jan 20SEC Rebecca TaubDirector Sell 2,238453,351 held (−0%) $490.77 $1.1M -3.9% —
Jan 20SEC Shannon T KelleyGeneral Counsel Sell Plan 4298,481 held (−5%) $501.40 $215K -5.9% —
Jan 20SEC Shannon T KelleyGeneral Counsel Sell Plan 2638,910 held (−3%) $490.77 $129K -3.9% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 2,432194,222 held (−1%) $525.05 $1.3M -10.2% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 2,450202,553 held (−1%) $517.86 $1.3M -8.9% —
Jan 13SEC Rebecca TaubDirector Sell Plan 2,044466,999 held (−0%) $517.84 $1.1M -8.9% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 1,996205,769 held (−1%) $515.81 $1.0M -8.5% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 1,560191,596 held (−1%) $526.97 $822K -10.5% —
Jan 13SEC Rebecca TaubDirector Sell Plan 1,578469,564 held (−0%) $515.82 $814K -8.5% —
Jan 13SEC Rebecca TaubDirector Sell Plan 1,489460,906 held (−0%) $525.12 $782K -10.2% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 1,480210,204 held (−1%) $511.98 $758K -7.9% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 1,363201,190 held (−1%) $518.68 $707K -9.0% —
Jan 13SEC Rebecca TaubDirector Sell Plan 1,335462,395 held (−0%) $524.06 $700K -10.0% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 1,345207,765 held (−1%) $514.68 $692K -8.3% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 1,199196,654 held (−1%) $524.10 $628K -10.0% —
Jan 13SEC Rebecca TaubDirector Sell Plan 1,135458,858 held (−0%) $526.95 $598K -10.5% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 1,094209,110 held (−1%) $513.11 $561K -8.1% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 1,066193,156 held (−1%) $526.00 $561K -10.3% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 970197,853 held (−0%) $523.00 $507K -9.8% —
Jan 13SEC Rebecca TaubDirector Sell Plan 970466,029 held (−0%) $518.67 $503K -9.0% —
Jan 13SEC Rebecca TaubDirector Sell Plan 960472,079 held (−0%) $513.12 $493K -8.1% —
Jan 13SEC Rebecca TaubDirector Sell Plan 960473,039 held (−0%) $512.02 $492K -7.9% —
Jan 13SEC Rebecca TaubDirector Sell Plan 937471,142 held (−0%) $514.63 $482K -8.3% —
Jan 13SEC Rebecca TaubDirector Sell Plan 913459,993 held (−0%) $526.05 $480K -10.3% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 846200,344 held (−0%) $519.88 $440K -9.3% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 840198,823 held (−0%) $521.98 $438K -9.6% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 766205,003 held (−0%) $516.84 $396K -8.7% —
Jan 13SEC Rebecca TaubDirector Sell Plan 732463,730 held (−0%) $522.98 $383K -9.8% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 691190,330 held (−0%) $529.17 $366K -10.9% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 681199,663 held (−0%) $521.03 $355K -9.5% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 600187,204 held (−0%) $540.36 $324K -12.7% —
Jan 13SEC Rebecca TaubDirector Sell Plan 588464,462 held (−0%) $521.95 $307K -9.6% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 575191,021 held (−0%) $528.18 $304K -10.7% —
Jan 13SEC Rebecca TaubDirector Sell Plan 554457,839 held (−0%) $529.28 $293K -10.9% —
Jan 13SEC Rebecca TaubDirector Sell Plan 539465,490 held (−0%) $519.89 $280K -9.3% —
Jan 13SEC Rebecca TaubDirector Sell Plan 521469,043 held (−0%) $516.81 $269K -8.7% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 487188,364 held (−0%) $536.88 $261K -12.1% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 480187,804 held (−0%) $539.23 $259K -12.5% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 473188,851 held (−0%) $536.02 $254K -12.0% —
Jan 13SEC Rebecca TaubDirector Sell Plan 465458,393 held (−0%) $528.16 $246K -10.7% —
Jan 13SEC Rebecca TaubDirector Sell Plan 440465,050 held (−0%) $521.11 $229K -9.5% —
Jan 13SEC Rebecca TaubDirector Sell Plan 400455,589 held (−0%) $542.72 $217K -13.1% —
Jan 13SEC Rebecca TaubDirector Sell Plan 400456,029 held (−0%) $539.26 $216K -12.5% —
Jan 13SEC Rebecca TaubDirector Sell Plan 385456,469 held (−0%) $536.88 $207K -12.1% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 332189,472 held (−0%) $534.16 $177K -11.7% —
Jan 13SEC Rebecca TaubDirector Sell Plan 299456,854 held (−0%) $535.80 $160K -12.0% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 280187,164 held (−0%) $551.24 $154K -14.4% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 280189,884 held (−0%) $530.69 $149K -11.1% —
Jan 13SEC Rebecca TaubDirector Sell Plan 271457,242 held (−0%) $534.18 $145K -11.7% —
Jan 13SEC Rebecca TaubDirector Sell Plan 256457,583 held (−0%) $530.45 $136K -11.1% —
Jan 13SEC Rebecca TaubDirector Sell Plan 200455,589 held (−0%) $551.24 $110K -14.4% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 166190,164 held (−0%) $529.76 $88K -11.0% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 148189,324 held (−0%) $535.29 $79K -11.9% —
Jan 13SEC Rebecca TaubDirector Sell Plan 89457,153 held (−0%) $534.93 $48K -11.8% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 80188,284 held (−0%) $537.85 $43K -12.3% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 80189,804 held (−0%) $532.50 $43K -11.4% —
Jan 13SEC Rebecca TaubDirector Sell Plan 40455,789 held (−0%) $545.79 $22K -13.6% —
Jan 13SEC Paul A FriedmanDirector Sell Plan 40187,164 held (−0%) $545.79 $22K -13.6% —
Jan 13SEC Rebecca TaubDirector Sell Plan 40455,989 held (−0%) $540.26 $22K -12.7% —
Jan 13SEC Rebecca TaubDirector Sell Plan 40456,429 held (−0%) $537.84 $22K -12.3% —
Jan 13SEC Rebecca TaubDirector Sell Plan 40457,513 held (−0%) $532.50 $21K -11.4% —
Jan 13SEC Rebecca TaubDirector Sell Plan 30457,553 held (−0%) $531.05 $16K -11.2% —
Dec 12SEC Paul A FriedmanDirector Sell Plan 7,193198,887 held (−3%) $551.67 $4.0M -14.5% —
Dec 12SEC Paul A FriedmanDirector Sell Plan 5,533193,354 held (−3%) $552.74 $3.1M -14.7% —
Dec 12SEC Paul A FriedmanDirector Sell Plan 5,001188,353 held (−3%) $553.83 $2.8M -14.8% —
Dec 12SEC Rebecca TaubDirector Sell Plan 4,723473,625 held (−1%) $550.99 $2.6M -14.4% —
Dec 12SEC Rebecca TaubDirector Sell Plan 4,410469,215 held (−1%) $551.85 $2.4M -14.5% —
Dec 12SEC Paul A FriedmanDirector Sell Plan 4,316206,080 held (−2%) $550.93 $2.4M -14.4% —
Dec 12SEC Rebecca TaubDirector Sell Plan 3,857465,358 held (−1%) $552.81 $2.1M -14.7% —
Dec 12SEC Rebecca TaubDirector Sell Plan 3,087462,271 held (−1%) $553.88 $1.7M -14.8% —
Dec 12SEC Paul A FriedmanDirector Sell Plan 1,029187,324 held (−1%) $555.00 $571K -15.0% —
Dec 12SEC Rebecca TaubDirector Sell Plan 1,027461,244 held (−0%) $554.84 $570K -15.0% —
Dec 12SEC Paul A FriedmanDirector Sell Plan 624211,340 held (−0%) $547.75 $342K -13.9% —
Dec 12SEC Paul A FriedmanDirector Sell Plan 535210,805 held (−0%) $548.51 $293K -14.0% —
Dec 12SEC Rebecca TaubDirector Sell Plan 491479,203 held (−0%) $547.76 $269K -13.9% —
Dec 12SEC Rebecca TaubDirector Sell Plan 486478,348 held (−0%) $550.07 $267K -14.2% —
Dec 12SEC Paul A FriedmanDirector Sell Plan 409210,396 held (−0%) $549.99 $225K -14.2% —
Dec 12SEC Rebecca TaubDirector Sell Plan 369478,834 held (−0%) $548.56 $202K -14.0% —
Dec 12SEC Rebecca TaubDirector Sell Plan 200461,044 held (−0%) $555.39 $111K -15.1% —
Dec 12SEC Paul A FriedmanDirector Sell Plan 160187,164 held (−0%) $555.39 $89K -15.1% —
Dec 4SEC William John SiboldCEO, President Sell 2,400150,074 held (−2%) $575.34 $1.4M -18.0% —
Dec 3SEC Mardi DierCFO Sell Plan 71712,812 held (−5%) $574.00 $412K -17.8% —
Dec 3SEC Mardi DierCFO Sell Plan 48011,394 held (−4%) $579.85 $278K -18.6% —
Dec 3SEC Mardi DierCFO Sell Plan 41013,883 held (−3%) $571.99 $235K -17.5% —
Dec 3SEC Mardi DierCFO Sell Plan 35413,529 held (−3%) $573.02 $203K -17.7% —
Dec 3SEC Mardi DierCFO Sell Plan 32012,132 held (−3%) $577.81 $185K -18.4% —
Dec 3SEC Mardi DierCFO Sell Plan 32014,293 held (−2%) $570.39 $183K -17.3% —
Dec 3SEC Mardi DierCFO Sell Plan 25811,874 held (−2%) $578.83 $149K -18.5% —
Dec 3SEC Mardi DierCFO Sell Plan 24010,914 held (−2%) $587.85 $141K -19.7% —
Dec 3SEC Mardi DierCFO Sell Plan 24011,154 held (−2%) $585.44 $141K -19.4% —
Dec 3SEC Mardi DierCFO Sell Plan 24012,452 held (−2%) $576.15 $138K -18.1% —
Dec 3SEC Mardi DierCFO Sell Plan 16010,594 held (−1%) $590.37 $94K -20.1% —
Dec 3SEC Mardi DierCFO Sell Plan 16010,754 held (−1%) $589.65 $94K -20.0% —
Dec 3SEC Mardi DierCFO Sell Plan 12012,692 held (−1%) $574.95 $69K -17.9% —
Dec 3SEC Mardi DierCFO Sell Plan 8010,440 held (−1%) $596.19 $48K -20.9% —
Dec 3SEC Mardi DierCFO Sell Plan 7410,520 held (−1%) $595.20 $44K -20.7% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 89411,096 held (−7%) $550.97 $493K -14.4% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 20010,232 held (−2%) $559.60 $112K -15.7% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 20010,592 held (−2%) $552.38 $110K -14.6% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 14410,952 held (−1%) $547.27 $79K -13.8% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 12010,432 held (−1%) $556.04 $67K -15.2% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 12010,832 held (−1%) $548.71 $66K -14.0% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 8010,032 held (−1%) $564.57 $45K -16.4% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 8010,152 held (−1%) $560.62 $45K -15.9% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 4010,112 held (−0%) $563.21 $23K -16.2% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 4010,552 held (−0%) $553.23 $22K -14.7% —
Nov 21SEC Carole HuntsmanChief Commercial Officer Sell Plan 4010,792 held (−0%) $549.34 $22K -14.1% —
Nov 14SEC Richard S LevyDirector Sell Plan 1,43422,961 held (−6%) $522.70 $750K -9.7% —
Nov 14SEC Richard S LevyDirector Sell Plan 1,35525,797 held (−5%) $519.67 $704K -9.2% —
Nov 14SEC Richard S LevyDirector Sell Plan 1,09424,395 held (−4%) $521.79 $571K -9.6% —
Nov 14SEC Richard S LevyDirector Sell Plan 91928,632 held (−3%) $515.64 $474K -8.5% —
Nov 14SEC Richard S LevyDirector Sell Plan 83527,152 held (−3%) $518.53 $433K -9.0% —
Nov 14SEC Richard S LevyDirector Sell Plan 81122,150 held (−4%) $523.66 $425K -9.9% —
Nov 14SEC Richard S LevyDirector Sell Plan 64527,987 held (−2%) $517.51 $334K -8.8% —
Nov 14SEC Richard S LevyDirector Sell Plan 44021,237 held (−2%) $528.60 $233K -10.8% —
Nov 14SEC Richard S LevyDirector Sell Plan 30825,489 held (−1%) $520.68 $160K -9.4% —
Nov 14SEC Richard S LevyDirector Sell Plan 20021,677 held (−1%) $527.85 $106K -10.6% —
Nov 14SEC Richard S LevyDirector Sell Plan 15321,997 held (−1%) $524.49 $80K -10.1% —
Nov 14SEC Richard S LevyDirector Sell Plan 14629,551 held (−0%) $514.67 $75K -8.3% —
Nov 14SEC Richard S LevyDirector Sell Plan 12021,877 held (−1%) $526.68 $63K -10.4% —
Nov 14SEC Richard S LevyDirector Sell Plan 4021,197 held (−0%) $530.21 $21K -11.0% —
Nov 7SEC Kenneth BateDirector Sell 3,25914,180 held (−19%) $481.13 $1.6M -1.9% —
Nov 7SEC Kenneth BateDirector Sell 2,7754,286 held (−39%) $487.49 $1.4M -3.2% —
Nov 7SEC Kenneth BateDirector Sell 2,06910,827 held (−16%) $483.41 $1.0M -2.4% —
Nov 7SEC Kenneth BateDirector Sell 1,9318,896 held (−18%) $484.78 $936K -2.7% —
Nov 7SEC Kenneth BateDirector Sell 1,76317,439 held (−9%) $480.24 $847K -1.8% —
Nov 7SEC Kenneth BateDirector Sell 1,28412,896 held (−9%) $482.41 $619K -2.2% —
Nov 7SEC Kenneth BateDirector Sell 1,0087,888 held (−11%) $485.54 $489K -2.8% —
Nov 7SEC Kenneth BateDirector Sell 9332,657 held (−26%) $489.95 $457K -3.7% —
Nov 7SEC Kenneth BateDirector Sell 8277,061 held (−10%) $486.73 $403K -3.1% —
Nov 7SEC Kenneth BateDirector Sell 6963,590 held (−16%) $489.09 $340K -3.5% —
Nov 7SEC Kenneth BateDirector Sell 302,627 held (−1%) $490.98 $15K -3.9% —

Insiders at MADRIGAL PHARMACEUTICALS, INC.

InsiderBoughtSoldLast filingScore
Paul A FriedmanDirector — $26.7M Jan 13, 2026 —
Rebecca TaubDirector — $21.7M Mar 6, 2026 —
William John SiboldCEO, President — $10.5M Sep 11, 2026 —
Kenneth BateDirector — $8.0M Nov 7, 2025 —
Richard S LevyDirector — $7.4M May 22, 2026 —
Mardi DierCFO — $3.8M Mar 6, 2026 —
Carole HuntsmanChief Commercial Officer — $1.7M Mar 6, 2026 —
David SoergelChief Medical Officer — $952K Jun 1, 2026 —
Shannon T KelleyGeneral Counsel — $842K Aug 20, 2026 —

MDGL stock: common questions

Are MADRIGAL PHARMACEUTICALS, INC. insiders buying MDGL stock?

In the past 12 months, 0 insiders reported open-market purchases of MDGL worth $0.

Are MADRIGAL PHARMACEUTICALS, INC. insiders selling MDGL stock?

9 insiders reported sales worth $81.5M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is MDGL's 52-week range?

Over the past year MDGL has traded between $412.35 and $602.83. It last closed at $471.75 on Oct 9, 2026.